This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaneko, S. Articles by Sugimachi, K. Search for Related Content PubMed PubMed Citation Articles by Kaneko, S. Articles by Sugimachi, K.

Nucleolar Organizer Regions as a Prognostic Indicator for Stage I Non-Small Cell Lung Cancer¹

Department of Surgery II, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812, Japan

When the number of silver-stained nucleolar organizer regions (Ag-NORs) was counted in 274 patients with non-small cell lung cancer, the mean number per nucleus in patients overall was 5.07 ± 1.92 (SD). With the use of the tumor (T)-nodes (N)-metastasis (M) classification, the mean Ag-NOR count for patients with T₁ and T₂ disease was statistically lower than that for those with T₃ and T₄ disease (P < 0.01). The mean Ag-NOR counts were lower in patients with N₀ disease than in those with N₁ and N₂ disease (P < 0.01); lower in patients with stage I disease than in those with stage II, IIIA, IIIB, or IV disease (P < 0.01); and lower in patients with adenocarcinoma than in those with squamous cell carcinoma (P < 0.01) or large-cell carcinoma (P < 0.05). In 131 patients with stage I disease, the mean Ag-NOR count was 3.80 ± 1.32, and the 5-year survival rates of patients with Ag-NOR counts of <3.80 and 3.80 were 78 and 44%, respectively, including 78% and 25% for adenocarcinoma, respectively (P < 0.01). However, there was no statistically significant difference for those in stage II, IIIA, IIIB, or IV, and in stage I (without an adenocarcinoma). Because patients with stage I non-small cell lung cancer and a high number of Ag-NORs had a poor prognosis, Ag-NORs can serve as a pertinent marker of an early recurrence.

¹ This work was supported in part by Grant-in-Aid for General Scientific Research 03670659 from the Japanese Ministry of Education, Science, and Culture.

² To whom requests for reprints should be addressed.

Received 2/28/91. Accepted 5/23/91.

This article has been cited by other articles:

				G. Sato, Y. Saijo, B. Uchiyama, N. Kumano, S.-i. Sugawara, S. Fujimura, M. Sato, M. Sagawa, K. Ohkuda, K. Koike, et al. Prognostic Value of Nucleolar Protein p120 in Patients With Resected Lung Adenocarcinoma J. Clin. Oncol., September 1, 1999; 17(9): 2721 - 2721. [Abstract] [Full Text] [PDF]

				A. Nishikawa, F. Furukawa, T. Imazawa, S. Ikezaki, T. Otoshi, S. Fukushima, and M. Takahashi Cell proliferation in lung fibrosis-associated hyperplastic lesions Human and Experimental Toxicology, September 1, 1995; 14(9): 701 - 705. [Abstract] [PDF]